Medtronic (MDT) Change in Cash (2014 - 2026)

Medtronic (MDT) has 13 years of Change in Cash data on file, last reported at $803.0 million in Q2 2026.

• For the quarter ending Q2 2026, Change in Cash fell 17.89% year-over-year to $803.0 million; the trailing twelve-month figure through Apr 2026 stood at -$269.0 million (down 128.8% YoY), and the FY2026 full-year result was -$269.0 million, down 128.8% from the prior year.
• Change in Cash improved to $803.0 million in Q2 2026, from -$136.0 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $2.7 billion in Q4 2022 to a low of -$3.0 billion in Q2 2023.
• A 5-year average of -$52.8 million and a median of -$9.5 million in 2023 frame the typical range for Change in Cash.
• Across the five-year window, Change in Cash jumped 2684.62% in 2022 and slumped 3600.0% in 2025, its largest moves.
• Tracing MDT's Change in Cash over 5 years: stood at $2.7 billion in 2022, then plunged by 101.04% to -$28.0 million in 2023, then surged by 396.43% to $83.0 million in 2024, then sank by 89.16% to $9.0 million in 2025, then jumped by 8822.22% to $803.0 million in 2026.
• Business Quant data shows MDT's Change in Cash at $803.0 million in Q2 2026, -$136.0 million in Q1 2026, and $9.0 million in Q4 2025.